France · Investor

Jeito Capital

Last cheque observed Jun 2026; 5 cheques on record.

Deploying nowVC firm

SeedSeries ASeries BHealthcareBiotech

Deploying now
100%of best year3cheques in 12 months, 5 on record
Since the last cheque131days00hrs00min00sec
Median round$165MRounds led3 of 5Mostly inFrance, 20%
Pitch Jeito Capital

Jeito Capital highlights

  1. 01

    3 cheques in the last 12 months

  2. 02

    Mostly Series A and Series B: 60% of its rounds

  3. 03

    Led 3 rounds

What they do

Jeito Capital is a global leading investment company with a patient benefit driven approach that finances and accelerates ground-breaking medical innovation.From their own website
Type
VC firm (from a list, unverified)
Cheque size
Not stated
Stages
SeedSeries ASeries BGrowth
Sectors
HealthcareBiotech
Based in
Paris, France
Cold pitches
Not stated

The record

Every round we can evidence, newest first5 appearances

  1. 2026

    3 rounds

  2. Jun
    Bionyra PharmaSeries A · FR · Ventureburn$165MLed
  3. Apr
    AdcendoSeries C · DK · Ventureburn$75MLed
  4. Feb
    Alveus Therapeutics Inc.Series A · US · Seroba Life Sciences$197MWith 8 others
  5. 2025

    1 round

  6. May
    AzafarosSeries B · NL · Seroba Life Sciences$147MLed
  7. 2024

    1 round

  8. Nov
    Alentis TherapeuticsSeries D · CH · Avego Management$181MWith 11 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

The team

Named by the firm itself, on a filing, its Form ADV or its company registration2 named

RMRachel MearsPartneriForm ADV
RTRafaele TordjmanManageriForm ADV

We also hold 10 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

What the register says

From the firm's own filings with the SEC, which it must file accurately by law

$572Mgross assets of its fundsOct 2026
Exemptreporting adviserventure or small private funds
Legal name
Jeito Capital SAS
SEC number
CRD 316494

What they claim to have backed

From their own portfolio page (on their website)

4 of 17 we have independently watched raise

theirtheirtheirtheirtheirtheirtheirtheirtheirtheirtheirtheirtheirtheirtheirtheirtheir

Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded.

Who they invest alongside

The investors most often in the same rounds as Jeito Capital. A count of rooms they were both in, not a relationship either has claimed.

Recently backed

The latest companies Jeito Capital put money into.

Quick answers about Jeito Capital

What does Jeito Capital invest in?

Jeito Capital invests most often at Series A and Series B (60% of the rounds on record), in sectors such as Healthcare and Biotech.

How active is Jeito Capital?

5 investments on record, 3 of them in the last 12 months, and it led 3. The most recent was in Jun 2026.

What has Jeito Capital invested in recently?

Its most recent investments on record: Bionyra Pharma (Series A, Jun 2026), Adcendo (Series C, Apr 2026) and Alveus Therapeutics Inc. (Series A, Feb 2026).

How big are Jeito Capital's cheques?

The median round it joins is $165M.

Does Jeito Capital lead rounds?

Yes: it led 3 of its 5 investments on record (60%).

Where does Jeito Capital invest?

Most of the companies it backs are in France (20%), Denmark (20%) and the United States (20%).

Is Jeito Capital investing now?

Yes: it is actively investing, with 3 investments in the last 12 months.

Who does Jeito Capital invest alongside?

Most often Novo Holdings (3 rounds together), Avego Bioscience Capital (2 rounds together) and Bpifrance (2 rounds together).

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it